Pharma in Focus
Email Address Sign-Up

Australia's most trusted source of pharma news

Special Report
PBAC March agenda

Posted 18 January 2021

The reimbursement committee will be very busy in March considering 35 major and 12 minor submissions covering forty disease areas.

Twenty of the major submissions are for new lisitngs and fifteen for changes to currently listed drugs with 28 sponors in all going to the expense of filing a major request.

Looks like you've lost your access to Pharma in Focus. To restore access or update your subscription, click here

Top of the Hill
How not to reform the PBAC
In the face of deep change, is piecemeal enough?
Approvals Action
New registrations for seizures and HIV
Eisai and ViiV add to their core franchises
Special Report
Aust Covid Vaccine Tracker
UPDATE: Distribution of two mRNA vaccines overseas